% | $
Quotes you view appear here for quick access.

Seattle Genetics, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • blackmenrock Nov 5, 2012 2:53 PM Flag

    Upcoming ASH studies: Adcetris + AVD achieves 92% complete remission rate in front-line Hodgkin and strong response in non-Hodg

    I traded back GM for SGEN today. The trade netted about $5 bucks, so it worked out. I still like GM also.
    I plan to stick around now but I still think it may show some weakness mid year 2013, Hopefully from a higher level.
    Still believe $100+ is in SGEN future.

35.48-1.81(-4.85%)Apr 29 4:00 PMEDT